Bank of New York Mellon Corp Raises Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Bank of New York Mellon Corp raised its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 14.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 68,700 shares of the company’s stock after purchasing an additional 8,887 shares during the period. Bank of New York Mellon Corp’s holdings in OrthoPediatrics were worth $1,976,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in KIDS. Braidwell LP increased its holdings in OrthoPediatrics by 4.7% in the 4th quarter. Braidwell LP now owns 1,107,770 shares of the company’s stock worth $36,014,000 after acquiring an additional 50,000 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of OrthoPediatrics by 1.3% during the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after purchasing an additional 11,100 shares in the last quarter. Granahan Investment Management LLC raised its position in shares of OrthoPediatrics by 30.0% during the 4th quarter. Granahan Investment Management LLC now owns 769,245 shares of the company’s stock worth $25,008,000 after purchasing an additional 177,640 shares during the last quarter. Wasatch Advisors LP lifted its stake in OrthoPediatrics by 21.2% in the 1st quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock valued at $14,618,000 after buying an additional 87,657 shares in the last quarter. Finally, AWM Investment Company Inc. boosted its holdings in OrthoPediatrics by 14.6% in the 1st quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock worth $14,219,000 after buying an additional 62,000 shares during the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on KIDS shares. JMP Securities reaffirmed a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a research note on Friday, September 13th. Truist Financial restated a “hold” rating and set a $34.00 price target (up from $30.00) on shares of OrthoPediatrics in a research report on Friday, September 13th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

Insider Buying and Selling

In related news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total transaction of $293,000.00. Following the transaction, the general counsel now owns 77,304 shares in the company, valued at approximately $2,265,007.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 31.80% of the stock is owned by company insiders.

OrthoPediatrics Trading Up 0.5 %

NASDAQ:KIDS opened at $31.08 on Wednesday. OrthoPediatrics Corp. has a 12-month low of $23.10 and a 12-month high of $36.23. The firm has a market cap of $740.61 million, a PE ratio of -32.38 and a beta of 1.18. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03. The stock has a fifty day moving average price of $30.80 and a 200 day moving average price of $30.20.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Monday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.08. The business had revenue of $52.80 million during the quarter, compared to analysts’ expectations of $52.40 million. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. Sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.96 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.